StockNow
Calendar
Log in
U.S. Markets

Pfizer (PFE) says new and acquired products have grown from USD 500mln in 2023 to USD 4bln; PFE cut opex by reallocating commercial resources toward priority markets

StockNow breaking-news AI analysis

Pfizer grew new and acquired product revenue from USD 500 million in 2023 to USD 4 billion while cutting opex by shifting commercial resources to priority markets.

1 stocks
PFEPfizer Inc.$27.73Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

Iranian Parliament Speaker Ghalibaf says US President Trump cannot impose his power on Iran, adding that Iran will neither shut down nor surrender

Geopolitics

IRGC says if Iran’s national interests require negotiations alongside war, then it must negotiate; says it will respond to any enemy strike with multiple strikes across different arenas and in various ways, Al Jazeera reports

Geopolitics

Senior Iranian Official says that Tehran welcomes revival of diplomacy if the US takes tangible steps